{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:14Z","timestamp":1790709374366,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjoms.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bjoms.2022.11.279","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:57:06Z","timestamp":1669726626000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?"],"prefix":"10.1016","volume":"61","author":[{"given":"Haleemah","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Attard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross O.C.","family":"Elledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjoms.2022.11.279_b0005","unstructured":"Durham J, Aggrawal V, Davies SJ, et al. Temporomandibular disorders (TMDs): an update and management guidance for primary care from the UK Specialist Interest Group in Orofacial Pain and TMDs (USOT). Royal College of Surgeons of England, 2013 (Clinical Standard Series)."},{"key":"10.1016\/j.bjoms.2022.11.279_b0010","unstructured":"National Institute of Dental and Craniofacial Research. Facial pain. Available from URL: https:\/\/www.nidcr.nih.gov\/research\/data-statistics\/facial-pain (last accessed 5 December 2022)."},{"key":"10.1016\/j.bjoms.2022.11.279_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00784-020-03710-w","article-title":"Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis","volume":"25","author":"Valesan","year":"2021","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.bjoms.2022.11.279_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2011.08.002","article-title":"Orofacial pain prospective evaluation and risk assessment study: the OPPERA study","volume":"12","author":"Maixner","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.bjoms.2022.11.279_b0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/AJP.0b013e31820215f5","article-title":"Temporomandibular disorders and associated clinical comorbidities","volume":"27","author":"Hoffmann","year":"2011","journal-title":"Clin J Pain"},{"issue":"3 Suppl","key":"10.1016\/j.bjoms.2022.11.279_b0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.bjoms.2022.11.279_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.11607\/jop.1151","article-title":"Diagnostic criteria for temporomandibular disorders (DC\/TMD) for clinical and research applications: recommendations of the International RDC\/TMD Consortium Network and Orofacial Pain Special Interest Group","volume":"28","author":"Schiffman","year":"2014","journal-title":"J Oral Facial Pain Headache"},{"key":"10.1016\/j.bjoms.2022.11.279_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aet125","article-title":"Differential diagnosis of facial pain and guidelines for management","volume":"111","author":"Zakrzewska","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjoms.2022.11.279_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/164_2019_273","article-title":"Clinical pharmacology of botulinum toxin drugs","volume":"263","author":"Dressler","year":"2021","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bjoms.2022.11.279_b0050","unstructured":"National Institute for Health and Care Excellence. Temporomandibular disorders (TMDs). Available from URL: https:\/\/cks.nice.org.uk\/topics\/temporomandibular-disorders-tmds (last accessed 5 December 2022)."},{"key":"10.1016\/j.bjoms.2022.11.279_b0055","unstructured":"Royal College of Physicians. Spasticity in adults: management using botulinum toxin. National guidelines 2018. Available from URL: file:\/\/\/C:\/Users\/User\/Downloads\/Spasticity%20in%20adults_final%20version_March%202019.pdf (last accessed 5 December 2022)."},{"key":"10.1016\/j.bjoms.2022.11.279_b0060","unstructured":"National Institute for Health and Care Excellence. Botulinum toxin type A. Available from URL: https:\/\/bnf.nice.org.uk\/drugs\/botulinum-toxin-type-a\/ (last accessed 5 December 2022)."},{"key":"10.1016\/j.bjoms.2022.11.279_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jormas.2018.10.007","article-title":"Improvement in quality of life after botulinum toxin injection for temporomandibular disorder","volume":"120","author":"Villa","year":"2019","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2022.11.279_b0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bjoms.2020.02.007","article-title":"Botulinum toxin in the management of temporomandibular disorders: a systematic review","volume":"58","author":"Thambar","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2022.11.279_b0075","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.pain.2011.03.036","article-title":"Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study","volume":"152","author":"Ernberg","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.bjoms.2022.11.279_b0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1179\/crn.2008.017","article-title":"Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study","volume":"26","author":"Guarda-Nardini","year":"2008","journal-title":"Cranio"},{"key":"10.1016\/j.bjoms.2022.11.279_b0085","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.joms.2008.03.008","article-title":"Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement","volume":"66","author":"Kurtoglu","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2022.11.279_b0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0304-3959(02)00240-3","article-title":"Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain","volume":"99","author":"Nixdorf","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.bjoms.2022.11.279_b0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0278-2391(03)00153-8","article-title":"Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity","volume":"61","author":"von Lindern","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2022.11.279_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/toxins12020112","article-title":"Use of botulinum toxin in orofacial clinical practice","volume":"12","author":"Serrera-Figallo","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bjoms.2022.11.279_b0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0003489417693013","article-title":"Incobotulinum toxin A injection for temporomandibular joint disorder","volume":"126","author":"Patel","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.bjoms.2022.11.279_b0110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijom.2015.04.003","article-title":"Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials","volume":"44","author":"Chen","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bjoms.2022.11.279_b0115","unstructured":"EMC. BOTOX 100 Units - Summary of product characteristics (SmPC). Available from URL: https:\/\/www.medicines.org.uk\/emc\/product\/859\/smpc (last accessed 5 December 2022)."},{"issue":"Suppl 8","key":"10.1016\/j.bjoms.2022.11.279_b0120","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/mds.20022","article-title":"Clinical presentation and management of antibody-induced failure of botulinum toxin therapy","volume":"19","author":"Dressler","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.bjoms.2022.11.279_b0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group","volume":"246","author":"Kessler","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.bjoms.2022.11.279_b0130","first-page":"73","article-title":"Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion","volume":"117","author":"Lim","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bjoms.2022.11.279_b0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/toxins12060395","article-title":"Efficacy and safety of botulinum toxin type A on persistent myofascial pain: a randomized clinical trial","volume":"12","author":"De la Torre","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bjoms.2022.11.279_b0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/toxins13010022","article-title":"The extreme ends of the treatment response spectrum to botulinum toxin in cervical dystonia","volume":"13","author":"Samadzadeh","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"6 Suppl","key":"10.1016\/j.bjoms.2022.11.279_b0145","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1097\/00002508-200211001-00013","article-title":"Treatment of temporomandibular disorders with botulinum toxin","volume":"18","author":"Schwartz","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bjoms.2022.11.279_b0150","unstructured":"National Institute for Health and Care Research. 22\/33 botulinum toxin in the management of chronic masticatory myofascial pain. Available from URL: https:\/\/www.nihr.ac.uk\/documents\/2233-botulinum-toxin-in-the-management-of-chronic-masticatory-myofascial-pain\/30110 (last accessed 5 December 2022)."}],"container-title":["British Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435622005848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0266435622005848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:31:42Z","timestamp":1759419102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0266435622005848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0266435622005848"],"URL":"https:\/\/doi.org\/10.1016\/j.bjoms.2022.11.279","relation":{},"ISSN":["0266-4356"],"issn-type":[{"value":"0266-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?","name":"articletitle","label":"Article Title"},{"value":"British Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjoms.2022.11.279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}